FAP and neoplasm: Interestingly, the FAP-IL and LipQ showed significantly higher tumor fluorescence levels than the mEnd-IL at 24–48 h post injection, suggesting a slower access of the targets (tumor-associated fibroblasts for the FAP-IL and macrophages for the LipQ) and hence a slower activation of the FAP-IL and LipQ in this tumor model.